A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
295 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Local Institution - 0011
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Not, yet, recruiting - Hospital Italiano de Buenos Aires
ABB, Buenos Aires F.D., Argentina
Recruiting - Hospital Italiano de Córdoba
Córdoba, Córdoba Province, Argentina
Recruiting - Centro Privado de Rmi Río Cuarto S.A. Ii
Río Cuarto, Córdoba Province, Argentina
Recruiting - Sanatorio Plaza
Rosario, Santa Fe Province, Argentina
Recruiting - Centro Oncologico Korben
Buenos Aires, Argentina
Recruiting - Instituto Alexander Fleming
Buenos Aires, Argentina
Recruiting - Instituto Argentino de Diagnóstico Y Tratamiento (iadt)
Buenos Aires, Argentina
Recruiting - Local Institution - 0346
Buenos Aires, Argentina
Not, yet, recruiting - Fundación Oncológica Mendoza
Mendoza, Argentina
Recruiting
- Macquarie University
Macquarie University, New South Wales, Australia
Recruiting - Royal Brisbane and Women'S Hospital
Brisbane, Queensland, Australia
Recruiting - Grampians Health
Ballarat Central, Victoria, Australia
Recruiting - Austin Health
Heidelberg, Victoria, Australia
Recruiting - Peter Maccallum Cancer Centre
Melbourne, Victoria, Australia
Recruiting - St. John of God Subiaco Hospital
Subiaco, Western Australia, Australia
Recruiting
- Medizinische Universität Graz
Graz, Styria, Austria
Recruiting - Medizinische Universitaet Innsbruck
Innsbruck, Tyrol, Austria
Recruiting - Uniklinikum Salzburg
Salzburg, Austria
Recruiting - Universitätsklinikum St. Pölten
Sankt Pölten, Austria
Recruiting - Medizinische Universität Wien
Vienna, Austria
Recruiting
- Local Institution - 0187
Manaus, Amazonas, Brazil
Withdrawn - Oncocentro Oncologia
Fortaleza, Ceará, Brazil
Recruiting - Cedoes
Vitória, Espírito Santo, Brazil
Recruiting - Local Institution - 1038
Lago Sul, Federal District, Brazil
Not, yet, recruiting - Centro Integrado de Oncologia de Curitiba
Curitiba, Paraná, Brazil
Recruiting - Futtura Oncology - Clinical Research Hub
Porto Alegre, Rio Grande do Sul, Brazil
Recruiting - Fundação Pio Xii - Hospital de Câncer de Barretos
Barretos, São Paulo, Brazil
Recruiting - Local Institution - 0164
São José do Rio Preto, São Paulo, Brazil
Not, yet, recruiting - Instituto Nacional de Câncer - Inca
Rio de Janeiro, Brazil
Recruiting - Clínica de Pesquisas E Centro de Estudos Em Oncologia Ginecológica E Mamária Ltda
São Paulo, Brazil
Recruiting - Instituto D'Or de Pesquisa E Ensino (idor)
São Paulo, Brazil
Recruiting
- Bc Cancer Kelowna
Kelowna, British Columbia, Canada
Recruiting - Local Institution - 0217
Victoria, British Columbia, Canada
Not, yet, recruiting - the Ottawa Hospital - General Campus
Ottawa, Ontario, Canada
Recruiting - Centre Hospitalier de L'Université de Montréal
Montreal, Quebec, Canada
Recruiting - Mcgill University Health Centre
Montreal, Quebec, Canada
Recruiting - Centre Intégré de Santé Et de Services Sociaux de Lanaudière
Saint-Charles-Borromée, Quebec, Canada
Recruiting - Centre Intégré Universitaire de Santé Et de Services Sociaux de L'Estrie - Centre Hospitalier Universitaire de Sherbrooke (cius
Sherbrooke, Quebec, Canada
Recruiting
- Bradfordhill
Santiago, Santiago Metropolitan, Chile
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Sept 2025
- Primary completion
- 13 Mar 2028
- Completion
- 15 May 2030
- Last update posted
- 10 Jun 2026
- Registered enrollment
- 500
- Registry id
- NCT06926868
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.